Tropé C - Search Results

1

Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4/AGO-OVAR-2.2 trial.

Parmar MK, Ledermann JA, Colombo N, du Bois A, Delaloye JF, Kristensen GB, Wheeler S, Swart AM, Qian W, Torri V, Floriani I, Jayson G, Lamont A, Tropé C; ICON and AGO Collaborators. Parmar MK, et al. Among authors: trope c. Lancet. 2003 Jun 21;361(9375):2099-106. doi: 10.1016/s0140-6736(03)13718-x. Lancet. 2003. PMID: 12826431 Clinical Trial.

2

Epithelial ovarian carcinoma.

Kristensen GB, Tropé C. Kristensen GB, et al. Among authors: trope c. Lancet. 1997 Jan 11;349(9045):113-7. doi: 10.1016/S0140-6736(96)06071-0. Lancet. 1997. PMID: 8996432 Review. No abstract available.

3

Current status of chemotherapy in gynecologic cancer.

Tropé C, Kristensen G. Tropé C, et al. Semin Oncol. 1997 Oct;24(5 Suppl 15):S15-1-S15-22. Semin Oncol. 1997. PMID: 9346216 Review. No abstract available.

4

Ten-year results of a randomised trial comparing cisplatin with cisplatin and cyclophosphamide in advanced, suboptimally debulked ovarian cancer.

Marth C, Tropé C, Vergote IB, Kristensen GB. Marth C, et al. Among authors: trope c. Eur J Cancer. 1998 Jul;34(8):1175-80. doi: 10.1016/s0959-8049(97)10171-x. Eur J Cancer. 1998. PMID: 9849475 Clinical Trial.

5

Long-term results from a phase II study of paclitaxel combined with doxorubicin in recurrent platinum refractory ovarian cancer.

Tropé C, Kristensen G, Kisic J, Kaern J. Tropé C, et al. Eur J Gynaecol Oncol. 2001;22(3):223-7. Eur J Gynaecol Oncol. 2001. PMID: 11501778 Clinical Trial.

6

A randomised study of cisplatin versus thiotepa as induction chemotherapy in advanced ovarian carcinoma.

Dørum A, Kristensen GB, Tropé C. Dørum A, et al. Among authors: trope c. Eur J Cancer. 1994;30A(10):1470-4. doi: 10.1016/0959-8049(94)00240-6. Eur J Cancer. 1994. PMID: 7833104 Clinical Trial.

7

Endometrial cancer: the management of high-risk disease.

Kristensen G, Tropé C. Kristensen G, et al. Among authors: trope c. Curr Oncol Rep. 2004 Nov;6(6):471-5. doi: 10.1007/s11912-004-0078-2. Curr Oncol Rep. 2004. PMID: 15485617 Review.

8

P-glycoprotein expression is a marker for chemotherapy resistance and prognosis in advanced ovarian cancer.

Baekelandt MM, Holm R, Nesland JM, Tropé CG, Kristensen GB. Baekelandt MM, et al. Among authors: trope cg. Anticancer Res. 2000 Mar-Apr;20(2B):1061-7. Anticancer Res. 2000. PMID: 10810398 Clinical Trial.

9

Effects of paclitaxel on CA-125 serum levels in ovarian cancer patients.

Paulsen T, Marth C, Kaern J, Nustad K, Kristensen GB, Tropé C. Paulsen T, et al. Among authors: trope c. Gynecol Oncol. 2000 Mar;76(3):326-30. doi: 10.1006/gyno.1999.5699. Gynecol Oncol. 2000. PMID: 10684705 Clinical Trial.

10

A phase II study of carboplatin and hexamethylmelamine as induction chemotherapy in advanced epithelial ovarian carcinoma.

Kristensen GB, Baekelandt M, Vergote IB, Tropé C. Kristensen GB, et al. Among authors: trope c. Eur J Cancer. 1995 Oct;31A(11):1778-80. doi: 10.1016/0959-8049(95)00274-m. Eur J Cancer. 1995. PMID: 8541099 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

452 results

Search Page

Filters